Coeptis Therapeutics (COEP) Stock: Buy, Sell, or Hold?
COEP - Coeptis Therapeutics Holdings Inc. Common Stock
$16.40
0.19 (1.17%)
â˛
5d:
+11.95%
30d:
+46.56%
90d:
+17.14%
WAIT
LOW Confidence
Analysis Updated: Apr 24, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When COEP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: COEP is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: COEP is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: COEP is currently trading at $16.40, which is considered fair based on recent price action.
Technical Outlook: Technically, COEP is in a downtrend. Immediate support is located at $11.51, while resistance sits at $17.27.
Market Sentiment: COEP scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $3.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, COEP is in a downtrend. Immediate support is located at $11.51, while resistance sits at $17.27.
Market Sentiment: COEP scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $3.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
41/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
71.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BEARISH: Trading 81.7% above Wall St target ($3.00)
- WARNING: Composite score 41/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$11.51
Resistance Level
$17.27
Current Trend
Downtrend
Technical data as of
Apr 24, 2026
Fundamental Context
Wall Street Target
$3.00
(-81.7%)
Revenue Growth (YoY)
1563.7%
Share & Embed Analysis
Last updated: October 04, 2026 1:38 AM ET
Data refreshes hourly during market hours. Next update: 2:38 AM
Data refreshes hourly during market hours. Next update: 2:38 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is COEP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
29 analysts |
$92 | 46 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 65 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
10 analysts |
$70 | 68 BUY |
